Background: Few peer-reviewed reports have been published that document the extent and type of use of published formularies in general practice. As publishers of the Practice Formulary of the Royal College of General Practitioners, the Northern Ireland Faculty Board commissioned a large-scale survey to quantify these issues, for the purpose of improving the revision process.
Aim: The aim of the survey was to investigate the extent to which general practitioners in Northern Ireland use the Practice Formulary and the ways in which they use it, and to elicit their opinions on ways in which it could be improved.
Results: A total of 371 completed questionnaires were received (response rate of 38%), 49 respondents (13%) stating that they had not received the formulary. Out of the 322 respondents who had received it, 84% used the formulary occasionally, and 41% either had or were producing their own practice formulary (32% of these had used the RCGP formulary in its production). Almost all respondents (90%) considered a formulary useful in general practice. The presentation and layout was approved by 273 respondents (85%) and 259 (80%) agreed strongly with the drug selection. The formulary was used as a source of drugs information by 191 respondents (59%) and as a teaching aid by 103 (32%). A total of 65 criticisms or suggestions for improving the next edition were received. Revision is now under way and 18 of the original respondents have volunteered to be members of the revision committee. No judgement was made about the non-respondents.
Conclusion: The largest survey yet conducted of published formulary use in one region elicited the extent of use, type of use, criticisms and suggestions for improvement. These suggestions are being used as a guide to revision of the next edition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1239695 | PMC |
J Family Med Prim Care
December 2024
Department of Pharmacology, All India Institute of Medical Sciences (AIIMS) Kalyani, Kalyani, West Bengal, India.
The novel approach of "Community Pharmacology" integrates pharmacological principles with community health to achieve the "Health for all" goal through safe and efficient health care. Pharmacovigilance, medication errors (ME), irrational prescriptions, and antimicrobial resistance in the community could be the key areas. Though life expectancy and other health indicators have improved in India, the disparity between rural and urban quality healthcare access should be addressed.
View Article and Find Full Text PDFTijdschr Psychiatr
January 2025
J Pharm Technol
December 2024
Department of Medicine, Larner College of Medicine, The University of Vermont, Burlington, VT, USA.
Infliximab is an anti-tumor necrosis factor agent used to treat rheumatologic disease. Evidence on the safety of switching to biosimilars and the associated risk factors for flares/loss of disease control within rheumatology is limited. The primary objective is to evaluate nonmedical switches from reference infliximab to biosimilars in rheumatology on risks and level of disease control.
View Article and Find Full Text PDFJ Pain Res
December 2024
Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Purpose: Gabapentinoids are mainly prescribed for neuropathic pain and certain seizure disorders, but their off-label use has increased significantly. This rise raises concerns about the insufficient evidence supporting some applications, as well as potential risks of misuse, dependence, and adverse effects. The study aims to examine the prescribing patterns and off-label use of gabapentinoids at Dhulikhel Hospital (DH), Nepal, focusing on understanding the extent of off-label practices and patient knowledge regarding their medications.
View Article and Find Full Text PDFBMC Emerg Med
December 2024
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA.
Background: Droperidol is a first-generation antipsychotic medication that has been used for various indications in the emergency department (ED); however, its use has been controversial due to reports of QT prolongation and the risk of torsades de pointes (TdP). The aim of the study is to evaluate the safety of droperidol administration in the ED.
Methods: This was a retrospective study, conducted at an academic level I trauma center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!